Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Kothari Fermentation & Biochem Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Statement of Deviation or Variation for the quarter ended December 31, 2016
Kothari Fermentation & Biochem Ltd has submitted to BSE a copy of Statement of Deviation or Variation under Regulation 32(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended December 31, 2016. Standalone Financial Results, Limited Review Report for September 30, 2016
Kothari Fermentation & Biochem Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 2016 Board Meeting Intimation for Results & Closure of Trading Window
Kothari Fermentation & Biochem Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on November 14, 2016, inter alia, to consider and approve the Unaudited Financial Results for the quarter ended on September 30, 2016.As per the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the Securities of the Company will remain closed for all Directors/Officers/ Designated... Shareholding for the Period Ended September 30, 2016
Kothari Fermentation & Biochem Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here Updates
Kothari Fermentation & Biochem Ltd has submitted to BSE a copy of Statement of Deviation or Variation in Public Issue, Rights Issue, Preferential Issue etc under Regulation 32(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended September 30, 2016. Though the same is not applicable to the Company, as there was no Rights Issue, Preferential Issue etc during the quarter ended September 30, 2016. Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Kothari Fermentation & Biochem Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Authorised KMPs to determine materiality of events/information
Kothari Fermentation & Biochem Ltd has informed BSE regarding "Authorised Key Managerial Personnel to determine materiality of events/information". Change in Company Secretary & Compliance Officer
Kothari Fermentation & Biochem Ltd has informed BSE that Mrs. Isha Gupta, who was designated as Company Secretary as well as Compliance Officer, has resigned from the services of the Company on effective close of working hours on September 30, 2016.Mrs. Kavita Tanwar, a qualified Company Secretary, has been appointed as the Company Secretary & Compliance Officer of the Company in place of Mrs. Isha Gupta w.e.f October 01, 2016 pursuant to Regulation 6 of the aforesaid regulations. Scrutinizer's Report
Kothari Fermentation & Biochem Ltd has submitted to BSE a copy of the Scrutinizers Report for 26th Annual General Meeting (AGM) of the Company held on September 28, 2016.